Cost-Effectiveness of Afatinib Versus Erlotinib for The Treatment of Squamous Non-Small Cell Lung Cancer in France After A First-Line Platinium Based Therapy
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.210
https://www.valueinhealthjournal.com/article/S1098-3015(17)30544-2/fulltext
Title :
Cost-Effectiveness of Afatinib Versus Erlotinib for The Treatment of Squamous Non-Small Cell Lung Cancer in France After A First-Line Platinium Based Therapy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30544-2&doi=10.1016/j.jval.2017.08.210
First page :
A434
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
190